187 related articles for article (PubMed ID: 29027812)
21. Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus.
Ito H; Abe M; Antoku S; Omoto T; Shinozaki M; Nishio S; Mifune M; Togane M
Drug Des Devel Ther; 2014; 8():391-6. PubMed ID: 24790413
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Structured Self-Monitoring of Blood Glucose Combined With Intensive Education on HbA1c Levels, Hospitalizations, and Quality-of-Life Parameters in Insulin-Treated Patients With Diabetes at Primary Care in Serbia: The Multicenter SPA-EDU Study.
Lalić NM; Lalić K; Jotić A; Stanojević D; Živojinović D; Janićijević A; Parkin C;
J Diabetes Sci Technol; 2017 Jul; 11(4):746-752. PubMed ID: 28625073
[TBL] [Abstract][Full Text] [Related]
23. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
24. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care.
Montero AR; Toro-Tobon D; Gann K; Nassar CM; Youssef GA; Magee MF
BMC Endocr Disord; 2021 Nov; 21(1):222. PubMed ID: 34758807
[TBL] [Abstract][Full Text] [Related]
25. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
26. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.
Yaron M; Roitman E; Aharon-Hananel G; Landau Z; Ganz T; Yanuv I; Rozenberg A; Karp M; Ish-Shalom M; Singer J; Wainstein J; Raz I
Diabetes Care; 2019 Jul; 42(7):1178-1184. PubMed ID: 31036546
[TBL] [Abstract][Full Text] [Related]
27. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
[TBL] [Abstract][Full Text] [Related]
28. Satisfaction with the Use of Different Technologies for Insulin Delivery and Glucose Monitoring Among Adults with Long-Standing Type 1 Diabetes and Problematic Hypoglycemia: 2-Year Follow-Up in the HypoCOMPaSS Randomized Clinical Trial.
Speight J; Holmes-Truscott E; Little SA; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
Diabetes Technol Ther; 2019 Nov; 21(11):619-626. PubMed ID: 31335201
[No Abstract] [Full Text] [Related]
29. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
30. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
[TBL] [Abstract][Full Text] [Related]
31. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
[TBL] [Abstract][Full Text] [Related]
32. Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus.
Chien MN; Chen YL; Hung YJ; Wang SY; Lu WT; Chen CH; Lin CL; Huang TP; Tsai MH; Tseng WK; Wu TJ; Ho C; Lin WY; Chen B; Chuang LM
J Diabetes Investig; 2016 Nov; 7(6):881-888. PubMed ID: 27181199
[TBL] [Abstract][Full Text] [Related]
33. IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Vigersky RA; Huang S; Cordero TL; Shin J; Lee SW; Chhabra H; Kaufman FR; Cohen O;
Endocr Pract; 2018 May; 24(5):446-452. PubMed ID: 29847166
[TBL] [Abstract][Full Text] [Related]
34. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA
Ruiz de Adana MS; Alhambra-Expósito MR; Muñoz-Garach A; Gonzalez-Molero I; Colomo N; Torres-Barea I; Aguilar-Diosdado M; Carral F; Serrano M; Martínez-Brocca MA; Duran A; Palomares R;
Diabetes Care; 2020 Feb; 43(2):337-342. PubMed ID: 31831473
[TBL] [Abstract][Full Text] [Related]
35. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
[TBL] [Abstract][Full Text] [Related]
36. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
[TBL] [Abstract][Full Text] [Related]
37. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life.
Polonsky WH; Fisher L; Hessler D; Edelman SV
Diabetes Technol Ther; 2015 Sep; 17(9):657-63. PubMed ID: 25923812
[TBL] [Abstract][Full Text] [Related]
38. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
39. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
Herrmann K; Frias JP; Edelman SV; Lutz K; Shan K; Chen S; Maggs D; Kolterman OG
Postgrad Med; 2013 May; 125(3):136-44. PubMed ID: 23748514
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
